Premier Alternatives

Mend (Pharmaceuticals and Biotechnology)

New York, NY · Founded 2014 · Privately Held (backing)

Developer of clinical nutritional products designed to assist people in healing and living a quality life. Mend (Pharmaceuticals and Biotechnology) is based in New York, NY and was founded in 2014. Its last reported valuation was $115 million in Feb 2026. It has raised $36.2 million.

Last reported valuation
$115.0M
Oct 2026
Priced at
—
Total raised
$36.2M
Last round
—
No prints on record

No secondary trades in Mend (Pharmaceuticals and Biotechnology) shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Mend (Pharmaceuticals and Biotechnology) with a free account
  • ·The complete investor list: 16 names
  • ·Watch Mend (Pharmaceuticals and Biotechnology): the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Where Mend (Pharmaceuticals and Biotechnology) prices come from

Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Mend (Pharmaceuticals and Biotechnology) stock.